Skip to content

Biodiversity Interventions for Assisted Living Centers

Biodiversity Interventions for Well-Being - Research in Assisted Living Centers

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06390683
Acronym
BIWE
Enrollment
36
Registered
2024-04-30
Start date
2023-02-01
Completion date
2027-09-30
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder, Immune System and Related Disorders, Microbial Colonization, Nature, Human, Visual Impairment, Well-Being, Psychological

Keywords

Biodiversity, Well-being, Planetary health, Commensal microbiome, Immune system

Brief summary

Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity in cities, which weakens the functionality of the urban ecosystems and the well-being of citizens. This may also increase the risk of immune-mediated disorders among urban dwellers. In Biodiversity interventions for assisted living centers (BIWE 2), microbial biodiversity interventions are performed to increase biodiversity in urban housing units for people with autism spectrum disorder, disabled people and elderly. Results from the intervention trials are combined with publicly available land cover and ecological data. These are analyzed from the viewpoint of shifts in ecosystems and human well-being and immune regulation, ecological quality, and urban planning. The investigators set up an intervention study in which yards of the housing units are rewilded with diverse vegetation and decaying deadwood and plant residuals. The investigators aim to evaluate the effect of rewilding, and yard management practices on commensal microbiome, cortisol levels and well-being and salivary cytokine levels, and gene pathways.

Detailed description

Our specific aims are: To assess if rewilding diversifies health-associated skin microbiota and is associated with salivary cytokine levels, gene pathways, cortisol levels and commensal microbiota. Assess whether there are patterns in the microbiome associated with the salivary cytokine levels and hair cortisol levels. Assess whether rewilding affects health and psychological measures. The investigators will recruit approximately 36 study subjects living in assisted housing units in urban areas and aged between 18-82.

Interventions

Yards of the assisted living centers will be modified with berry bushes, fruit trees, perennial yard plants, meadow flowers, cultivation boxes, organic mulch materials, decaying deadwood, leaf compost and organic plant growing media with high microbial diversity.

Sponsors

Tampere University
CollaboratorOTHER
Natural Resources Institute Finland
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 82 Years
Healthy volunteers
Yes

Inclusion criteria

* Person lives in assisted living center

Exclusion criteria

* Immunosuppressive medications * Immune deficiencies * a disease affecting immune response (colitis ulcerosa, rheumatoid arthritis, Crohn's disease, diabetes) * cancer diagnosis within the last year or on-going cancer treatment

Design outcomes

Primary

MeasureTime frameDescription
Skin GammaproteobacteriaBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearChange in skin gammaproteobacterial diversity

Secondary

MeasureTime frameDescription
Salivary cytokinesBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearInterleukin-6 and -10 measured from saliva
Skin bacteriaBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearChanges in skin bacteria are analyzed with Illumina 16s rRNA sequencing.
Saliva microbiotaBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearChanges in saliva microbiota are analyzed with shotgun sequencing.
Saliva gene pathwaysBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearChanges in salivary gene pathways are analyzed with shotgun sequencing.
Cortisol levelsBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearCortisol levels measured from hair samples
Warwick-Edinburgh Mental Wellbeing ScaleBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearIncrease in Warwick-Edinburhg Mental Wellbeing scale score during the study period that indicates better mental well-being. Minimum 14, maximum 70.
Depression ScaleBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearDecrease in depression scale score during the study period that indicates lower levels of depression symptoms. Minimum 0, maximum 70.
Nature Relatedness ScaleBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearIncrease in Nature Relatedness scale during the study period that indicates stronger sense of connectedness to nature. Minimum 6, maximum 30.
Changes in nature contactsBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearIncrease in time that study subjects are in contact with nature during the study period.
Infectious diseasesBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearInfectious diseases are recorded with questionnaires.
Perceived Stress ScaleBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearDecrease in perceived stress scale score during the study period that indicates lower perceived stress levels. Minimum 0, maximum 40.

Other

MeasureTime frameDescription
Associations between environmental factors and primary and secondary outcomesBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 yearassociations between environmental factors (vegetation, deadwood, and polypore richness, land cover categories and other yard characteristics), yard management practices, activities at the yard, salivary cytokine and hair cortisol levels, prevalence of infectious diseases, psychological parameters, and microbial measurements (diversity, and taxonomic and functional features).

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026